Skip to content
GLP-1 Scorecard
Menu
Graded #108

REMEVi

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Visit REMEViWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$199/mo (starting dose, compounded)
Tirzepatide
$269/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Compounded only

Weigh REMEVi against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because REMEVi dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value54/100
Dose & formulation64/100
Clinical oversight86/100
Labs & monitoring65/100
Fulfillment97/100
Contract terms69/100

Strengths

  • The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
  • Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
  • LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
  • Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)

Where it loses points

  • Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
  • The specific compounding pharmacy is not named (described as 'NPI-verified')
  • A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements

Bottom line — Grade C

Best for: Shoppers who want spanish-speaking patients wanting bilingual, LegitScript-certified compounded GLP-1.

Ranked #108 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest REMEVi — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect REMEVi's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to the scorecard